Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History BIVI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics BIVI

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Biovie Inc

BIVI
Current price
8.47 USD -0.21 USD (-2.42%)
Last closed 0.96 USD
ISIN US09074F4054
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 17 827 872 USD
Yield for 12 month -79.35 %
1Y
3Y
5Y
10Y
15Y
BIVI
21.11.2021 - 28.11.2021

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease. The company develops BIV201 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada. Address: 680 West Nye Lane, Carson City, NV, United States, 89703

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6.00 USD

P/E Ratio

Dividend Yield

Financials BIVI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures BIVI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-229 000 USD

Last Year

-267 000 USD

Current Quarter

-57 344 USD

Last Quarter

-57 344 USD
EBITDA -18 964 038 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -42.51 %
PEG Ratio
Return On Equity TTM -93.24 %
Wall Street Target Price 6.00 USD
Revenue TTM
Book Value 1.18 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -13.30 USD
Diluted Eps TTM -13.30 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation BIVI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -11.66
Price Book MRQ 8.17

Technical Indicators BIVI

For 52 Weeks

0.62 USD 4.77 USD
50 Day MA 1.04 USD
Shares Short Prior Month 1 447 857
200 Day MA 1.69 USD
Short Ratio 4.98
Shares Short 1 227 779
Short Percent 7.60 %